Latest in Pfizer
Sort by
5 items
-
Pfizer CEO ‘disappointed’ by Kennedy’s refusal to rebut claims on jab risks
Albert Bourla says Donald Trump’s nominee for health secretary still appeared to ‘temper’ some of his viewsFinancial Times - 1h -
Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off
The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its Covid business and stock price.CNBC - 1h -
Pfizer’s stock falls despite fourth-quarter revenue and earnings beat. This analyst expects growth to accelerate.
Pfizer Inc. shares fell 2% Tuesday despite the drugmaker topping Wall Street’s revenue and profit estimates in its fourth-quarter results.MarketWatch - 4h -
Pfizer Sells 700 Million Haleon Shares for $3 Billion
The sale decreases Pfizer’s shareholding in the consumer-healthcare business to 7.3% of its issued share capital, down from 15%.The Wall Street Journal - Jan. 15 -
Pfizer executives descend on Trump’s Mar-a-Lago for planning meeting
Drugmaker becomes latest titan of corporate America to curry favour with president-electFinancial Times - Jan. 7
